Why Are Altimmune Shares Trading Lower Wednesday?
Why Are Altimmune Shares Trading Lower Wednesday?
Altimmune, Inc. (NASDAQ:ALT) shares are experiencing significant movement lower following the unexpected passing of Richard Eisenstadt, the company's chief financial officer.
纳斯达克的altimmune股票价格出现明显下跌，因为该公司首席财务官理查德 · 艾森施塔特意外离世。
What To Know: Eisenstadt's sudden death has deeply saddened Altimmune, with CEO Vipin K. Garg highlighting his contributions and personal qualities that endeared him to colleagues.
要知道：艾森施塔特的意外去世让Altimmune深感悲痛，首席执行官Vipin K.Garg强调他的贡献和个人素质让他深得同事们的喜爱。
In response to Eisenstadt's passing, Altimmune's finance and accounting functions are temporarily being managed by the existing team while the company initiates a search for his replacement. This transition period aims to maintain stability amid the loss of a key executive.
为了应对艾森施塔特的离世，Altimmune的财务和会计职能将由现有团队暂时管理，同时公司启动了寻找他的接替者的过渡期以保持稳定。
Altimmune is a clinical-stage biopharmaceutical firm specializing in next-generation peptide-based therapeutics, notably developing pemvidutide for treating obesity and non-alcoholic steatohepatitis (NASH). The company remains committed to advancing its pipeline despite this unexpected setback.
Altimmune是一家专注于下一代基于肽的治疗方案的临床阶段生物医药公司，尤其是开发用于治疗肥胖症和非酒精性脂肪肝（NASH）的pemvidutide。尽管遭受意外挫折，该公司仍致力于推进其新药研发项目。
ALT Price Action: Altimmune shares were down at market close Wednesday by 15.59% at $6.26, according to Benzinga Pro.
Altimmune的股票价格下跌15.59％，收于6.26美元。
Photo: Via Pixabay.
照片：通过Pixabay。